A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia

Br J Haematol. 2018 Oct;183(2):298-301. doi: 10.1111/bjh.14950. Epub 2017 Sep 29.

¹ Haematology-Oncology Laboratory, Istituto di Ricerca Pediatrica (IRP) - Fondazione Città della Speranza, Padova, Italy.
² Women and Child Health Department, Haematology-Oncology Clinic and Laboratory, University of Padova, Padova, Italy.
³ Department of Women's and Children's Health, Padova University Hospital, Padua, Italy.
⁴ Department of Paediatric Haemato-Oncology, Santobono-Pausilipon Hospital, Napoli, Italy.
⁵ Department of Paediatrics, Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy.
⁶ Department of Paediatrics, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.
⁷ Department of Paediatric Oncohaematology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
⁸ Department of Paediatric Science, University of Pavia, Pavia, Italy.

No abstract available

Keywords: miRNA; miRNA signature; paediatric AML; relapse; t(8;21)RUNX1-RUNX1T1.

Publication types